SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved the ...
Xolair is a branded injectable medication used to treat allergic asthma, chronic hives, and rhinosinusitis. It’s recently been approved to manage food allergies, reducing the risk of serious reactions ...
XOLAIR is given in 1 or more injections under the skin (subcutaneous), 1 time every 2 or 4 weeks. In people with asthma, CRSwNP and food allergy, a blood test for a substance called IgE must be ...
The U.S. Food and Drug Administration (FDA) has approved a medication for use in treating severe food allergies, and the agency says that this injection is the first of its kind. The drug, which has ...
About 20 million people in the U.S.—including four million children—have food allergies. Now, there's a new way to reduce their risk of severe allergic reactions. A study published in the New England ...
PALO ALTO, Calif. (KGO) -- Researchers at Stanford say a newly approved drug treatment could change the lives of millions of children with food allergies. While it's not a cure, they say it can ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new positive data from Stage 2 and Stage 3 of the National Institutes ...
Chances are, you may know a family living with food allergies. Food allergies are more prevalent than many realize, particularly among children in the United States. In 2024, an estimated 3.4 million ...
CHICAGO (WLS) -- After the FDA approved a medication called Xolair to help lessen the severity of an accidental allergic reaction in people who are allergic to multiple foods, sufferers say they're ...
A new study finds that the asthma medication Xolair may substantially reduce severe allergic reactions in people who have multiple food allergies and are accidentally exposed to those foods. Data ...
Roche announced that the US Food and Drug Administration (FDA) has approved the company’s supplemental Biologics License Application (sBLA) for Xolair (omalizumab) prefilled syringe for self-injection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback